oldrunnerguy
Explorer
John Teasley, who serves as market executive at Wells Fargo Healthcare Banking, spoke with FOX Business and said GLP-1s might be sold to the public as weight-loss medications, yet they are quickly turning into one of the most disruptive economic forces in healthcare. According to him, what we have here is a drug class capable of altering the way providers bring in revenue, the places where investors put their capital, and the manner in which consumers interact with their own health.
Link is here: https://www.foxbusiness.com/healthcare/how-glp-1-weight-loss-drugs-reshaping-healthcare-industry.amp
"how consumers engage with their health". Seriously, tell me something I don't know.
Link is here: https://www.foxbusiness.com/healthcare/how-glp-1-weight-loss-drugs-reshaping-healthcare-industry.amp
"how consumers engage with their health". Seriously, tell me something I don't know.